Commentary: GM1-Gangliosidosis Type III Associated Parkinsonism. [PDF]
Kurian MA +9 more
europepmc +1 more source
Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B. [PDF]
Pérez-Carmona N +11 more
europepmc +1 more source
Extensive Telangiectasias and Mongolian Spots: A Clue towards GM1-Gangliosidosis.
Gupta S, Patel V, Garg S, Mehta N.
europepmc +1 more source
From amaurotic idiocy to biochemically defined lipid storage diseases: the first identification of GM1-Gangliosidosis. [PDF]
Kasper BS +4 more
europepmc +1 more source
Clinical, Radiological, and Genetic Profiles of Eight Patients with Combined Dystonic Manifestation of Type-III GM1 Gangliosidosis: A Video Case Series from India. [PDF]
Roy S +9 more
europepmc +1 more source
VaProS: a database-integration approach for protein/genome information retrieval [PDF]
core +1 more source
Four novel mutations in patients from the Middle East with the infantile form of GM1-gangliosidosis. [PDF]
Caciotti, A +9 more
core +1 more source
Impact of Sinbaglustat on Neurons of the Medial Nucleus of the Trapezoid Body in a Murine Model of Human G<sub>M1</sub>-Gangliosidosis. [PDF]
Jubran L +6 more
europepmc +1 more source
Founder mutation causing infantile GM1-gangliosidosis in the Gypsy population [PDF]
Chandler, D. +7 more
core +1 more source
Imaging manifestations in infantile GM1 gangliosidosis: a rare lysosomal storage disorder: a paediatric case report. [PDF]
Bhat S, Sharma S, Bhat S, Kaul A.
europepmc +1 more source

